Synergistic Effect of Nanoparticles with Probiotics on Gastrointestinal Regenerative Medicine
- PMID: 40778962
- DOI: 10.1007/s12602-025-10707-y
Synergistic Effect of Nanoparticles with Probiotics on Gastrointestinal Regenerative Medicine
Abstract
Nanomedicine has emerged as a prominent field with significant potential to transform the future of medicine, thereby attracting considerable attention from researchers worldwide. In various studies, nanoparticles with high potential as delivery systems have been used in combination with probiotics, microorganisms that have beneficial health effects when consumed in sufficient doses, in treating inflammatory bowel disease, including ulcerative colitis and Crohn's disease. Nanoparticles are synthesized by various methods, including biological, physical, and chemical, and depending on their size and structure, they produce different effects on the digestive system when combined with probiotics. The study demonstrates that combining various nanoparticles with specific probiotics can effectively modulate intestinal microbiota, reduce inflammation, enhance mucosal barrier function, and boost antioxidant activity, thereby aiding in the treatment of inflammatory digestive diseases. So, future research should further investigate the long-term safety, optimal dosing, and mechanisms of action of these nanoparticle-probiotic combinations in clinical settings to maximize therapeutic benefits.
Keywords: Gastrointestinal; Nanoparticles; Probiotics; Regenerative medicine.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Abady MM, Mohammed DM, Soliman TN, Shalaby RA, Sakr FA (2025) Sustainable synthesis of nanomaterials using different renewable sources. Bull Natl Res Cent 49(1):24
-
- Akhtar N, Pathak K (2017) Probiotics as a tool to biosynthesize metallic nanoparticles: research reports and patents survey. Recent Pat Drug Deliv Formul 11(1):5–18 - PubMed
-
- Alkushi AG, Abdelfattah-Hassan A, Eldoumani H, Elazab ST, Mohamed SA, Metwally AS, S. El-Shetry E, Saleh AA, ElSawy NA, Ibrahim D (2022) Probiotics-loaded nanoparticles attenuated colon inflammation, oxidative stress, and apoptosis in colitis. Sci Rep 12(1):5116
-
- Alkushi AG, Elazab ST, Abdelfattah-Hassan A, Mahfouz H, Salem GA, Sheraiba NI, Mohamed EA, Attia MS, El-Shetry ES, Saleh AA (2022) Multi-strain-probiotic-loaded nanoparticles reduced colon inflammation and orchestrated the expressions of tight junction, NLRP3 inflammasome and Caspase-1 genes in DSS-induced colitis model. Pharmaceutics 14(6):1183 - PubMed - PMC
-
- Allan J, Belz S, Hoeveler A, Hugas M, Okuda H, Patri A, Rauscher H, Silva P, Slikker WSokull-Kluettgen B (2021) Regulatory landscape of nanotechnology and nanoplastics from a global perspective. Regul Toxicol Pharmacol 122:104885
Publication types
LinkOut - more resources
Full Text Sources
